Share-based Payment Arrangement, Expense of Sight Sciences, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sight Sciences, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Sight Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,421,000, a 44% decline year-over-year.
  • Sight Sciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $14,451,000, a 13% decline year-over-year.
  • Sight Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $17,077,000, a 17% increase from 2023.
  • Sight Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14,581,000, a 12% increase from 2022.
  • Sight Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12,963,000, a 155% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Sight Sciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $14,451,000 $2,421,000 -$1,887,000 -44% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $16,338,000 $3,841,000 -$476,000 -11% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $16,814,000 $4,243,000 -$263,000 -5.8% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $17,077,000 $3,946,000 +$486,000 +14% 01 Oct 2024 31 Dec 2024 10-K 07 Mar 2025 2024 FY
Q3 2024 $16,591,000 $4,308,000 +$452,000 +12% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $16,139,000 $4,317,000 +$575,000 +15% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $15,564,000 $4,506,000 +$983,000 +28% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $14,581,000 $3,460,000 +$226,000 +7% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $14,355,000 $3,856,000 +$633,000 +20% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $13,722,000 $3,742,000 +$210,000 +5.9% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $13,512,000 $3,523,000 +$549,000 +18% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q4 2022 $12,963,000 $3,234,000 +$1,258,000 +64% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $11,705,000 $3,223,000 +$1,324,000 +70% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $10,381,000 $3,532,000 +$2,601,000 +279% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $7,780,000 $2,974,000 +$2,697,000 +974% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 $5,083,000 $1,976,000 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $1,899,000 +$1,734,000 +1051% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $931,000 +$866,000 +1332% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $277,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q3 2020 $165,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $65,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2

Sight Sciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $17,077,000 +$2,496,000 +17% 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025 2024 FY
2023 $14,581,000 +$1,618,000 +12% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
2022 $12,963,000 +$7,880,000 +155% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $5,083,000 +$4,586,000 +923% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $497,000 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.